Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,361
Closed -$116K 2045
2021
Q2
$116K Buy
+1,361
New +$124K ﹤0.01% 2120
2021
Q1
Sell
-4,186
Closed -$244K 2077
2020
Q4
$244K Buy
4,186
+2,366
+130% +$111K ﹤0.01% 1634
2020
Q3
$62K Buy
+1,820
New +$68.9K ﹤0.01% 1626

Other funds holding AFMD

Michael Gelband's AFMD Position: Q3 2021 in Review

Michael Gelband sold out of Affimed (AFMD) in Q3 2021, closing a stake of 1,361 shares — an estimated $116K sold.

Michael Gelband first reported a position in AFMD in Q3 2020 and held it in 3 quarters. The position peaked at $244K in Q4 2020. 126 funds tracked by Wall St. Rank hold AFMD as of Q3 2021.

  • Michael Gelband reported no remaining Affimed position as of Q3 2021 after selling out during the quarter.
  • Michael Gelband sold 1,361 Affimed shares in Q3 2021, an estimated $116K.
  • Michael Gelband first reported a position in Affimed in Q3 2020 and held it in 3 quarters.
  • Michael Gelband's Affimed position peaked at $244K in Q4 2020.
  • 126 funds tracked by Wall St. Rank held Affimed as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.